2016 was a big year for patent law. Five patent cases were argued at the U.S. Supreme Court. Gilead Sciences Inc. got hit with a $200 million infringement verdict in March, and though it was quickly overturned, the figure turned out to be small potatoes compared to the $2.5 billion verdict Gilead sustained just this month.
But instead of focusing on the biggest cases, we hereby present five of the quirkiest patent cases that crossed the U.S. Court of Appeals for the Federal Circuit’s docket this year.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
